0001574251-18-000001.txt : 20181016 0001574251-18-000001.hdr.sgml : 20181016 20181016103622 ACCESSION NUMBER: 0001574251-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181016 DATE AS OF CHANGE: 20181016 EFFECTIVENESS DATE: 20181016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mati Therapeutics Inc. CENTRAL INDEX KEY: 0001574251 IRS NUMBER: 462000931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-323613 FILM NUMBER: 181123728 BUSINESS ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 329-6360 MAIL ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0708 D LIVE 0001574251 Mati Therapeutics Inc. 4317 DUNNING LANE AUSTIN TX TEXAS 78746 (512) 329-6360 DELAWARE None None Corporation true Robert Lee Butchofsky II 4317 Dunning Lane Austin TX TEXAS 78746 Executive Officer Director Cameron Nelson 3505 West 36th Avenue Vancouver A1 BRITISH COLUMBIA, CANADA V6N 251 Executive Officer Christopher Muller 3 Verona Lane Foothill Ranch CA CALIFORNIA 92610 Executive Officer Director Deepank Utkhede 18623-68th Avenue Surrey A1 BRITISH COLUMBIA, CANADA V3S9CI CA Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-10-01 false true false 0 1200000 50000 1150000 false 1 0 0 0 false Mati Therapeutics Inc. /S/ ROBERT LEE BUTCHOFSKY II Robert Lee Butchofsky II Chief Executive Officer 2018-10-10